Reducing pharmacists' racial bias to improve HIV prevention for people of color

The Impact of an Intervention to Reduce Pharmacists' Racial Bias Towards People of Color at Risk of HIV

NIH-funded research Massachusetts General Hospital · NIH-11009359

This study is looking at ways to help pharmacists be more aware of and reduce racial bias so that people of color can get better access to PrEP, a medication that helps prevent HIV, making sure everyone gets the care they need.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11009359 on NIH RePORTER

What this research studies

This research investigates how to reduce racial bias among pharmacists to improve access to pre-exposure prophylaxis (PrEP) for people of color at risk of HIV. It focuses on the role of community pharmacies, where pharmacists can build trust and provide essential care. The project aims to implement training and interventions that address implicit bias, ensuring that all patients receive equitable care. By enhancing the effectiveness of pharmacist-led PrEP programs, the research seeks to improve health outcomes for marginalized communities.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals of color who are at risk of HIV and seeking pre-exposure prophylaxis (PrEP).

Not a fit: Patients who are not at risk of HIV or those who do not seek PrEP services may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to increased access to HIV prevention methods for people of color, ultimately reducing HIV infection rates.

How similar studies have performed: Previous research has shown that addressing implicit bias in healthcare can improve patient outcomes, suggesting that this approach may be effective.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.